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Background: Elevated levels of reactive oxygen species (ROS) are detected in 25% to 80% of infertile men. They are
involved in the pathology of male infertility. Understanding the effect of increasing levels of ROS on the differential
expression of sperm proteins is important to understand the cellular processes and or/pathways that may be
implicated in male infertility. The aim of this study was to examine differentially expressed proteins (DEPs) in
spermatozoa from patients with low, medium and high ROS levels.
Methods: A total of 42 infertile men presenting for infertility and 17 proven fertile men were enrolled in the study.
ROS levels were measured by chemiluminescence assay. Infertile men were divided into Low (0- < 93 RLU/s/106 sperm)
(n = 11), Medium (>93-500 RLU/s/106 sperm) (n = 17) and High ROS (>500 RLU/s/106 sperm) group (n = 14). All fertile
men had ROS levels between 4-50 RLU/s/106 sperm. 4 subjects from fertile group and 4 each from the Low, Medium
and High ROS were pooled. Protein extraction, protein estimation, gel separation of the proteins, in-gel digestion,
LTQ-orbitrap elite hybrid mass spectrometry system was conducted. The DEPs, the cellular localization and pathways of
DEPs involved were examined utilizing bioinformatics tools.
Results: 1035 proteins were identified in the 3 groups by global proteomic analysis. Of these, 305 were DEPs. 51 were
unique to the Low ROS group, 47 Medium ROS group and 104 were unique to the High ROS group. 6 DEPs were
identified by Uniprot and DAVID that had distinct reproductive functions and they were expressed only in 3 ROS
groups but not in the control.
Conclusions: We have for the first time demonstrated the presence of 6 DEPs with distinct reproductive functions only
in men with low, medium or high ROS levels. These DEPs can serve as potential biomarkers of oxidative stress induced
male infertility.
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Infertility is defined as the inability to achieve a preg-
nancy after one year of unprotected intercourse [1].
Male factor infertility accounts for almost 40% of infer-
tility problems, and another 40% is attributed to the fe-
male, while in about 20%, it is due to both male and
female factors [2]. The etiology of male infertility is
multifactorial, and in about 20% of the cases, the eti-
ology is unknown or idiopathic [3]. Varicocele is present* Correspondence: agarwaa@ccf.org
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unless otherwise stated.in about 15% of the male population, and in about 40%
of men presenting with male infertility, which makes it
the most common cause of male infertility [4]. The ma-
jority of the causes of male infertility are treatable or
preventable, so a keen understanding of these conditions
is paramount [5].
Oxidative stress results from the imbalance between
reactive oxygen species (ROS) and the antioxidants that
neutralize these excessive free radicals [6]. Oxidative
stress results in abnormal semen parameters and [7] is
strongly correlated with male infertility [8,9]. When used
in conjunction with conventional semen analysis, oxida-
tive stress can help differentiate between fertile andhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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infertile men who may benefit from antioxidant sup-
plementation [7]. Factors such as lifestyle (smoking),
environmental (pesticide, air pollution, electromagnetic
radiation), and health (chemotherapy, urogenital infec-
tion, prostatitis) can significantly alter the balance be-
tween ROS levels and total antioxidant capacity, disrupt
sperm plasma membrane fluidity, impair sperm motility
and induce sperm DNA damage [3,7].
Elevated levels of ROS are detected in 25% to 80% of in-
fertile men [10]. Infertile men are also reported to have
significantly lower reserves of antioxidants in their seminal
plasma compared to their fertile counterparts [11-13].
Men with elevated ROS are also less likely to achieve a
spontaneous pregnancy. Using chemiluminescence, the
most common method used to measure ROS levels in
the seminal ejaculates [14], we have identified that ROS
levels <90 Relative Light Units per second per million
spermatozoa (RLU/s/ X 106 sperm) in the ejaculate are
considered normal in fertile men (unpublished work). We
also found that infertile men and those with unexplained or
idiopathic infertility have ROS levels that are significantly
higher than 90 RLU/s/106 sperm (unpublished work).
Proteomics is developing rapidly as a promising field
in the assessment of male infertility. Novel tools devel-
oped in the last decade have helped identify more than
6000 different sperm proteins. In addition to identifica-
tion of unique sperm proteins that may contribute to
male infertility, quantitative proteomics can help to de-
termine the physiological and pathological function of
these proteins with respect to their cellular localization
and biological processes [15]. Differential expression of a
specific protein may be used as a biomarker acting as a
non-invasive diagnostic tool [16]. We have recently identi-
fied differentially expressed proteins (DEPs) in the sperm-
atozoa and seminal plasma from subjects exhibiting high
levels of ROS in the seminal ejaculates [17,18]. Under-
standing the differential expression of sperm proteins is
the key to understanding the cellular processes and or/
pathways that may be implicated in male infertility [19].
The goal of this study is to determine the effect of in-
creasing presence of ROS in the seminal ejaculate on the
human spermatozoa proteome in male infertility patients.
ROS levels in the seminal ejaculates of infertile men, cate-
gorized as low, medium and high were compared to healthy
fertile men with physiological levels of ROS. To our know-
ledge, this is the first study that is aimed at understanding
the impact of ROS levels on sperm protein alterations, bio-
logical functions and signaling pathways in infertile men.
Methods
Sample collection
Following approval from the Institutional Review Board
of Cleveland Clinic, semen samples were collected frommale infertility patients with different oxidative stress
levels (n = 42) as well as healthy men of proven fertility
(n =17). All subjects provided written consent to be en-
rolled in this prospective study.
Inclusion/exclusion criteria
Male infertility patients 20-40 years of age who pre-
sented for infertility were enrolled in the study from
March 2012 to March 2014. All female partners of the
infertile men had undergone gynecologic evaluation and
had normal results on fertility assessment. Patients were
excluded if they had a recurring fever in the 90-day
period prior to semen analysis. Patients with leukocytos-
permia, azoospermia and oligozoospermia were not in-
cluded in the study.
Semen analysis
All specimens were collected by masturbation at the
Andrology Laboratory after 2-3 days of sexual abstin-
ence. Samples were allowed to liquefy completely for
15-30 minutes at 37°C and manual semen analysis was per-
formed using a MicroCell counting chamber (Vitrolife, San
Diego, CA) to determine sperm concentration and motil-
ity. Smears of the raw semen were stained with a Diff-Quik
kit (Baxter Healthcare Corporation, Inc., McGaw Park, IL)
for assessment of sperm morphology according to WHO
criteria [20]. Sample was tested for Leukoctyospermia,
i.e. >1 X 106 WBC/mL when the round cell concentration
was >1 X 106m/mL. This was confirmed by the peroxidase
or the Endtz test [17].
Reactive oxygen species (ROS) measurement
ROS formation was measured by chemiluminescence assay
using luminol (5-amino-2, 3-dihydro-1, 4-phthalazinedione)
as the probe. Chemiluminescence was measured for
15 min using a Berthold luminometer (Autolumat Plus
953, Oakridge, TN). Results were expressed as relative
light units (RLU)/sec/X106 sperm [14]. ROS concentration
was divided into three categories:
Low ROS group: ROS levels 0- < 93 RLU/sec/X 106
sperm
Medium ROS: ROS levels >93-500 RLU/sec/X 106
sperm
High ROS group: ROS concentration > 500 RLU/sec/X 106
Pooling of samples and protein extraction
Pooling of samples is common in proteomic studies.
However, it is important to have equal contribution of
sperm from each pool. The number is based on the
amount of proteins necessary to conduct the proposed
measurement of sperm concentration and running of
the gel for proteomic analysis. For normalizing the
sperm and protein concentration needed for proteomic
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100 X 106 sperm are required to give about 1.5 mg/mL
of protein. 20 μL of protein are loaded in triplicate for
each run. Therefore about 75 -100 μL of protein aliquot
with a protein concentration of about 1.5 mg/mL is ad-
equate. To accomplish this, we pooled 4 samples from
each group.
For proteomic analysis, we pooled 4 subjects from the
fertile group and 4 subjects each from the low, medium
and High ROS group in the infertile men. Equal number
of spermatozoa were pooled from patients in each group
and washed with PBS three times. Once the super-
natant was removed, the spermatozoa were solubilized
in radio-immunoprecipitation assay (RIPA) lysis buffer
(Sigma-Aldrich, St. Louis, MO) containing the proteinase
inhibitor cocktail (Roche, Indianapolis, IN). After com-
plete lysis of the spermatozoa, protein concentration was
determined using a bicinchoninic acid (BCA) kit (Thermo,
Rockford, IL) and equal amounts of proteins was fraction-
ated using SDS-Page 1D gel electrophoresis.
Twelve bands were cut from a single Coomassie blue
stained 1D gel and analyzed in triplicate. The bands were
washed, reduced, alkylated, and digested with trypsin. The
completely digested extracts were eluted on LC-MS system,
and the CID spectra searched against the human reference
sequence database. These samples were analyzed using an
LC gradient from 2 to 70% acetonitrile in 120 minutes. All
of these chromatograms contained several peaks indicating
efficient digestion of the samples.
Global proteomics analysis
Samples were mixed with SDS Page buffer and separated
on a 1D gel. For the protein digestion, the bands were
cut to minimize excess polyacrylamide, divided into a
number of smaller pieces. The gel pieces were washed
with water and dehydrated in acetonitrile. The bands
were then reduced with dithiothreitol (DTT) and alky-
lated with iodoacetamide prior to the in-gel digestion.
All bands were digested in-gel using trypsin, by adding
5 μL 10 ng/μL trypsin in 50 mM ammonium bicar-
bonate and incubated overnight at room temperature
to achieve complete digestion. The peptides that were
formed were extracted from the polyacrylamide in
two aliquots of 30 μL 50% acetonitrile with 5% formic
acid. These extracts were combined and evaporated
to <10 μL in Speedvac and then resuspended in 1% acetic
acid to make up a final volume of ~30 μL for LC-MS
analysis [21].
The LC-MS system was a Finnigan LTQ-Obitrap Elite
hybrid mass spectrometer system. The HPLC column
was a Dionex 15 cm × 75 μm internal diameter Acclaim
Pepmap C18, 2 μm, 100 Å reverse phase capillary chro-
matography column. Five μL volumes of the extract were
injected and the peptides eluted from the column by anacetonitrile/0.1% formic acid gradient at a flow rate of
0.3 μL/min were introduced into the source of the mass
spectrometer on-line. The microelectrospray ion source
is operated at 1.9 kV. The digest was analyzed using
the data dependent multitask capability of the instru-
ment acquiring full scan mass spectra to determine
peptide molecular weights and product ion spectra to
determine amino acid sequence in successive instrument
scans.
Data analysis
For semen parameters, comparison was made between
fertile men and patients as well as fertile men and pa-
tients in each ROS group by Wilcoxon–rank sum test.
Database searching
Tandem mass spectra were extracted by Proteome
Discoverer version 1.4.1.288. Charge state deconvolu-
tion and de-isotoping were not performed. All MS/
MS samples were analyzed using Mascot (Matrix Science,
London, UK; version 2.3.02), SEQUEST (Thermo Fisher
Scientific, San Jose, CA, USA; version 1.4.0.288) and X!
Tandem (The GPM, thegpm.org; version CYCLONE
(2010.12.01.1). Mascot, Sequest and X! Tandem were set
up to search the human reference with database (33,292
entries) assuming trypsin as the digestion enzyme. These
searches were performed with a fragment ion mass toler-
ance of 0.8 Da, and a parent ion tolerance of 10 parts per
million (PPM). Carbamidomethylation of cysteine was
specified as a fixed modification, and oxidation of methio-
nine was specified as a variable modification.
Criteria for protein identification
To validate MS/MS-based peptide and protein identifi-
cations Scaffold (version 4.0.6.1, Proteome Software Inc.,
Portland, OR) was used. Peptide identifications were ac-
cepted if they could be established at >95.0% probability
by the Peptide Prophet algorithm [22] with Scaffold
delta-mass correction. Protein identifications were ac-
cepted if they could be established at > 99.0% probability
to achieve a false discovery rate (FDR) of <1.0% and con-
tained at least 2 identified peptides. Protein probabilities
were assigned by the Protein Prophet algorithm [23].
Proteins that contained similar peptides and could not
be differentiated based on MS/MS analysis alone were
grouped to satisfy the principles of parsimony. Proteins
were annotated with gene ontology (GO) terms from
National Center for Biotechnology Information (NCBI)
(downloaded Oct 21, 2013) [24].
Quantitative proteomics
For proteomic analysis, the relative quantity of the pro-
teins was determined by comparing the number of spec-
tra, termed spectral counts (SpCs), used to identify each








Age (y) 34.2 ± 7.5 34.6 ± 6.9 0.76
Volume (mL) 3.6 ± 1.4 3.2 ± 1.5 0.68
Concentration (106/mL) 53.60 ± 46.98 29.77 ± 33.09 0.005
Motility (%) 47.7 ± 13.7 39.6 ± 19.2 0.13
Normal morphology
(Strict criteria %)
7.7 ± 2.6 2.1 ± 1.5 <0.001
ROS (RLU/s/106 sperm)* 27.7 (4.6, 45.9) 174.4 (0, 982.9) 0.024
*Values are median (25th, 75th percentile). P<0.05 was considered significant
by Wilcoxon-rank sum test.
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matched peptides to a particular protein was used to
measure the abundance of proteins in the complex mix-
ture. Normalization of spectral counts using the NSAF
(normalized spectral abundance factor) approach was
applied prior to relative protein quantification. DEPs
were obtained by applying different constraints for sig-
nificance tests and/or fold-change cutoffs based on the
average SpC of the protein from multiple runs.
Appropriate filters were used to identify DEPs that
were dependent on the overall abundance of the pro-
teins. It has been reported [25] that accurate quantifica-
tion and determination of real biological change is
dependent on the number of SpCs and hence different
constraints have to be applied to SpC levels in order to
circumvent the biases and maintain a constant false
positive ratio (FPR) for all proteins. The abundance of
the proteins was classified as High (H), Medium (M),
Low (L), or Very Low (VL) based on their average spectral
counts amongst the 3 replicate runs. Different constraints
for significance tests (p-value) and/or fold change cutoffs
(or NSAF ratio) were applied for these 4 abundance cat-
egories, as shown below:
Very Low abundance: spectral count range 1.7-7;
p ≤ 0.001 and NSAF ratio ≥ 2.5 for Upregulated, ≤ 0.4
for Downregulated proteins
Low abundance: spectral count range 8-19; p ≤ 0.01
and NSAF ratio ≥2.5 for Upregulated, ≤ 0.4 for
Downregulated proteins
Medium abundance: spectral count range between
20-79; p ≤ 0.05 and NSAF ratio ≥ 2.0 for
Upregulated, ≤ 0.5 for Downregulated proteins
High abundance: spectral counts >80; p ≤ 0.05 and
NSAF ratio ≥ 1.5 for Upregulated, ≤ 0.67 for
Downregulated proteins
Bioinformatics analysis
Functional annotation and enrichment analysis were per-
formed using publicly available bioinformatics annotation
tools and databases such as GO Term Finder [26], GO
Term Mapper, UniProt, Software Tools for Researching
Annotations of Proteins (STRAP) [27], Database for An-
notation, Visualization and Integrated Discovery (DAVID)
(http://david.niaid.nih.gov), and proprietary software pack-
age such as IPA (Ingenuity Pathway Analysis) from
Ingenuity® Systems, used to obtain consensus-based, com-
prehensive functional context for the large list of proteins
derived from proteomic study.
Results
Semen analysis
Semen analysis results for fertile men, infertile patient
group, and the ROS (low, medium, high) groups areshown in Tables 1 and 2. Sperm concentration, morph-
ology and ROS levels were significantly different among
the fertile men and infertile men. Among the 17 fertile
men, ROS levels were between 4-50 RLU (physiological
levels). Of the 42 infertile men, 11 men had Low ROS
levels between 0 - <93 RLU/sec/106 sperm, 17 had Medium
ROS group levels >93 - 500 RLU/sec/106 sperm and 14 had
high ROS levels >500 RLU/sec/106 sperm.
Among the different ROS groups, sperm concentra-
tion, motility, and morphology were significantly re-
duced in the high ROS group compared to the fertile
group. Semen parameters in the other two ROS groups
were comparable with the fertile group.Analysis of spermatozoa proteins
The number of proteins identified from the LC-MS/MS
analysis of spermatozoa from fertile men was 1337, from
patients with Low ROS was 1297, Medium ROS was
1280 and High ROS was 1331 respectively (Additional
file 1: Table S2a, Additional file 2: Table S2b, Additional
file 3: Table S2c, and Additional file 4: Table S2d). From
the total proteins identified in each group, the number
of proteins identified in:
 all three replicates were 1205 (90%) in
fertile men and 1132 (87%), 1094 (85%), 1133
(85%) in the Low, Medium and High ROS groups
respectively.
 two of the three replicates were 72 (5%) in fertile
men and 107 (8%), 114 (9%), 125 (9%) in the Low,
Medium and High ROS groups respectively.
 one of three replicates was 60 (4%) in fertile men
and 61 (5%), 72 (6%), 73 (5%) in the Low, Medium
and High ROS groups respectively.
Some of the more abundant proteins found in the fer-
tile group (Additional file 1: Table S2a) as well as in the
3 ROS groups (Additional file 2: Table S2b, Additional
file 3: Table S2c and Additional file 4: Table S2d) were
Table 2 Semen parameters in fertile men and low medium and high ROS in infertile patients
Parameter Fertile men (n = 17) Low ROS (n = 17) Medium ROS (n = 11) High ROS (n = 14) P valuea P valueb P valuec
Age (y) 34.2 ± 7.5 34.3 ± 4.8 33.8 ± 6.8 35.7 ± 9.0 0.73 0.96 0.71
Volume (mL) 3.6 ± 1.4 2.7 ± 1.8 3.3 ± 1.4 3.8 ± 1.1 0.21 0.79 0.51
Concentration (106/mL) 53.60 ± 46.98 33.49 ± 33.25 36.43 ± 32.56 20.02 ± 33.45 0.07 0.17 0.001
Motility (%) 47.7 ± 13.7 40.1 ± 23.9 45.9 ± 11.3 34.0 ± 17.1 0.41 0.94 0.006
Normal morphology
(Strict criteria %)
7.7 ± 2.6 2.0 ± 1.4 1.6 ± 1.1 2.5 ± 1.8 <0.001 <0.001 <0.001
ROS (RLU/s/106 sperm)* 27.7 (4.6, 45.9) 0 (0, 12.7) 189.2 (131.5, 320.1) 2003.2 (924.2, 9395) 0.02 <0.001 <0.001
aP value comparison between donors and low ROS patients.
bP value comparison between donors and medium ROS patients.
cP value comparison between donors and high ROS patients by Wilcoxon-rank sum test.
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nemal isoform X1 and fibronectin isoform 3.
Common proteins in low, medium and high ROS groups
A total of 1035 proteins were commonly expressed in
the 3 groups. 102 proteins were only identified in the
Low ROS group; 101 proteins in the medium ROS group
and 145 in the High ROS group (Figure 1A).
Differentially expressed proteins
Based on the filtering criteria described in the Methods
section, the total number of DEPs obtained were 305.
Proteins that were unique, similar, or common to the
3 (Low, Medium, and High) ROS groups are shown in
Figure 1B:
 33 DEPs were identified as common to all 3
(Low, Medium and High) ROS groups when
compared to the control group.
 In the Low ROS group: 132 DEPs were observed. Of
these, 51 were unique, 29 were similar to Medium
ROS and 19 were similar to High ROS.Figure 1 Venn diagram showing A: global proteomic analysis and B:
and High ROS group. In the Medium ROS group: 131 DEPs were
obtained. Of these, 47 were unique, 29 were similar
to Low ROS and 22 were similar to High ROS.
 In the High ROS group: a higher number of DEPs
(178) were expressed compared to the other two
groups. Of the 178 DEPs, 104 were unique, 19 were
similar to Low ROS, and 22 were similar to Medium
ROS.
The distribution of overexpressed (OE), underexpressed
(UE), and unique proteins in each of the three categories
(Low, Medium and High ROS) and the control group is
shown in Figure 2A:
 Of the 132 DEPs in the Low ROS group: 37 were
OE and 84 were UE respectively compared to the
control group. 4 DEP were expressed only in the
Low ROS group and 7 DEP were expressed only in
the control group.
 Of the 131 DEPs in the Medium ROS group: 44
were OE and 66 were UE respectively compared to
the control group. 9 DEP were expressed only in thedistribution of differentially expressed proteins in Low, Medium
Figure 2 Distribution and protein abundance in low, medium and high ROS groups A: overexpressed (OE), underexpressed (UE) and
unique (Uq) B: high, medium, low and very low abundance proteins.
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only in the control group.
 Of the 178 DEPs in the High ROS group: 76 were
OE and 80 were UE respectively compared to the
control group. 15 DEP were expressed only in the
High ROS group and 7 DEP were expressed only
in the control group.
The abundance of DEPs in the 3 (Low, Medium, and
High) ROS groups is shown in Figure 2B.
 High Abundance proteins: 25 proteins were
differentially expressed in the Low ROS group,
20 in the Medium ROS group and 36 in the
High ROS group.
 Medium Abundance proteins: 31 proteins were
differentially expressed in the Low ROS group,
30 in the Medium ROS group and 52 in the
High ROS group.
 Low Abundance proteins: 38 differentially expressed
proteins were identified in the Low ROS group,32 in the medium ROS group and 45 in the
High ROS group.
 Very Low Abundance proteins: 31 differentially
expressed proteins were identified in the Low ROS
group, 37 in the Medium ROS group and 38 in the
High ROS group.
Reactome pathway analysis
From the Reactome analysis of DEPs, distribution of a
select set of pathway categories (either associated with
or known to affect reproductive functions) in each of the
three groups is shown in Figures 3, 4 and 5.
Low ROS versus fertile control group
 A total of 37 proteins were overexpressed in this
group (Figure 3A).
 Some of the DEP were involved in the innate and
adaptive immune system, metabolism of proteins,
membrane trafficking, disease and developmental
biology.
Figure 3 Reactome analysis of DEPs involved in major reproductive functions in Low ROS group when compared to the fertile control
group that were A: Overexpressed B: Underexpressed; C: Uniquely expressed proteins in fertile control group only and D: Uniquely
expressed proteins in Low ROS group only.
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metabolism, diseases, signal transduction,
and in the immune system (Figure 3B).
 Proteins that were uniquely expressed in the
fertile control group only (Figure 3C) were
involved in metabolism, signal transduction and
disease, whereas 14% of the DEPs were involved
in each category such as immune system,
developmental biology, biological oxidations and
apoptosis.
 Proteins that were uniquely expressed in
the low ROS group shown in Figure 3D were
Toll-like receptor 9, Toll-like receptor cascade,
innate immune system and adaptive immune
system.Medium ROS versus fertile control group
 44 DEP were overexpressed in this group
(Figure 4A).
 They were involved in metabolism of
proteins, disease, extracellular matrix
organization, metabolism, and immune system
(Figure 4A).
 7% of the proteins were involved in each category
such as post-translational protein modifications,
developmental biology and signal transduction
(Figure 4A).
 66 of the DEP were underexpressed in medium
ROS group (Figure 4B) and were involved in
metabolism, disease related pathways, signal
Figure 4 Reactome analysis of DEPs involved in major reproductive functions in Medium ROS group when compared to the fertile
control group that were A: Overexpressed B: Underexpressed; C: Uniquely expressed proteins in fertile control group only and
D: Uniquely expressed proteins in Low ROS group only.
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and a small percentage in immune system,
apoptosis and post-translational protein
modifications.
 Uniquely expressed proteins in the fertile control
group only that were differentially expressed were
involved in metabolism, signaling by Robo receptor,
developmental biology and disease as shown in
Figure 4C.
 9 DEP were uniquely expressed in the medium ROS
group were involved in metabolism, while 11% of
the proteins were uniquely involved in each of the
categories such as toll-like receptor cascades, cell
cycle, and immune system and gene expression as
shown in Figure 4D.High ROS versus fertile control group
 76 of the DEP were overexpressed in the High ROS
group compared to the fertile control group
(Figure 5A).
 The overexpressed proteins were involved in
metabolism, immune system, disease, and
extracellular matrix organization, developmental
biology, and signal transduction, membrane
trafficking and cellular responses to stress (Figure 5A).
 80 DEPs were underexpressed and were involved
in metabolism, disease, metabolism of lipids and
lipoproteins, immune system, cell cycle, signal
transduction, and cellular responses to stress
(Figure 5B).
Figure 5 Reactome analysis of DEPs involved in major reproductive functions in High ROS group when compared to the fertile control
group that were A: Overexpressed B: Underexpressed; C: Uniquely expressed proteins in fertile control group only and D: Uniquely
expressed proteins in Low ROS group only.
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fertile control group and were involved in
electron transport, mitochondrial iron-sulphur
cluster biogenesis, and synthesis of PIPs at the
Golgi membrane, phospholipid metabolism,
metabolism of lipids and lipoproteins and general
metabolism (Figure 5C).
 15 DEP were uniquely expressed in the
High ROS group (Figure 5D) and involved in
metabolism, disease, metabolism of lipids
and lipoproteins, immune system, cell cycle,
signal transduction and cellular response
to stress.DAVID software’s functional annotations in low, medium
and high ROS group
The results of the functional annotation analysis of
DEPs using DAVID software is shown in Table 3. In
the Low ROS compared to the control group, 12
DEPs involved in reproduction and fertilization were
under-expressed. In the Medium ROS group, 109 DEP
were under-expressed. Some of the functions were
related to sexual reproduction, gamete generation and
reproductive process. 44 DEPs participating in reproduc-
tion, spermatogenesis, spermatid development and dif-
ferentiation were under-expressed in the High ROS
group.
Table 3 Functional Annotations analysis of DEPs by DAVIDS analysis in low, medium and high ROS group
Functional
annotations





Single fertilization (4), sexual reproduction (8) Sexual reproduction (7), gamete
generation (96), reproductive process in
multicellular organism (6)
Sexual reproduction (11), multicellular
organism reproduction (10), gamete
generation (9), spermatogenesis (8),
spermatid development/differentiation




Cell cortex (5), actin binding (5),
myofibril (3), protease (4), peptidase
activity (4), metal ion binding (12),
protein targeting (3), IC protein
transport and localization (3), cell cycle
phase (3), nucleotide binding (5),
regulation of transcription (3); lysosome
(7), influence lipid concentrations and risk
of CAD (4), plasma lipoprotein particle
remodeling (3), heparin binding (5),
protein-lipid complex (3), glucose
metabolic process (5), cytoskeleton
organization (6), sterol transport and
homeostasis (3), EGF-like region (5), cellular
response to stress (3), negative regulation of
apoptosis (6), cell migration (5), cell cycle (3)
Basement membrane (6), EC matrix (6),
ECM-receptor interaction (5), EGF
domain (5), cell motility and localization
(6), cytoplasmic vesicle (6), regulation of
neurological system process (3), motor
protein (3), calmodulin binding (3),
metal ion binding (16) cellular ion
homeostasis (3), cell morphogenesis (3),
protein targeting and localization (3),
synaptic transmission (3), ATP binding
(5); Dynein (6), microtubule associated
complex (6), motor activity (6), negative
regulation of cellular metabolic process
(5), Ca binding region (4), cytoskeleton
organization (5), gamete generation (6),
reproductive process in multicellular
organism (6), nucleotide biosynthetic
process (4), nucleotide binding (12),
metalloendopeptidase activity (3),
glycosaminoglycan binding (3),
phospholipid metabolic process (3),
regulation of apoptosis (6), cytoskeleton
(11), metal ion binding (12)
Oxidoreductase (12), Protease (11),
cofactor binding (8), metallopeptidase
activity (7), metalloprotease (7), zinc
ion binding (13), cytoskeleton (14), cell
junction (6), regulation of apoptosis
(7), intracellular protein transport and
localization (5), proteasome complex
(3), vasculature development (4), focal
adhesion (4); nucleotide binding (24),
sexual reproduction (11), multicellular
organism reproduction (10), gamete
generation (9), spermatogenesis (8),
spermatid development/differentiation
(3), germ cell development (3),
glutathione S-transferase (3), peroxisome
(4), fatty acid oxidation (3), lipid
modification (3), glycerolipid metabolic
process (4), protein targeting (3), metal






(22), acetylation (15), glycoprotein (13),
Golgi (9); polymorphism (62), signal
peptide (38), glycoprotein (36), disulfide
bond (34), extracellular (30), acetylation (26),
secreted (23), oxidoreductase (11), lipid
binding (11)
Phosphoprotein (26), glycoprotein
(20), signal peptide (18), disulfide
bond (15), acetylation (13), cytoplasm
(13), Golgi (10), EC region (11),
secreted (10), Ca ion binding (8), cell
adhesion (7); Polymorphism (50), Signal
peptide (18), EC (17), secreted (15),
mitochondrion (13), nucleotide binding
(15), cell fraction (10), cytoskeleton (9),
sexual reproduction (7)
Polymorphism (57), phosphoprotein
(41), ion binding (34), glycoprotein
(27), cytoplasm (26), signal peptide
(22), cell membrane (16), proteolysis
(14), hydrolase (15), oxidoreductase
(12), defense response (9),
metalloprotease (7), protein transport
and localization (8), exopeptidase
activity (6), adherens junction (6), cell
migration (6); purine nucleotide binding
(24), ribonucleotide binding (22), sexual
reproduction (11), gamete generation
(9), spermatogenesis (8), mitochondrion
(15), reproductive cellular process (5),




Cell cortex (5), Golgi (9), cytoskeleton (9),
cytosol (8), ER (6), organelle envelope (5),
vesicle (5), sarcomere (3); extracellular
region (30), cytosol (13), lysosome (7),
vesicle (11), secretory granule (4),
protein-lipid complex (3), cell surface (6),
golgi (10)
Golgi (10), EC region (9), organelle
membrane (9), ER (8), proteinaceous
ECM (6), cytoplasmic vesicle (6),
intrinsic to plasma membrane (8);
dynein complex (6), mitochondrion (13),
EC region (17), microtubule cytoskeleton
(8), cell projection (8), cytoskeleton (11),
cilium (4)
Actin cytoskeleton (10), cell cortex (7),
cortical cytoskeleton (5), cell-cell
adherens junction (4), vesicle (11), Golgi
(12), EC region (19), mitochondrial
lumen (4); mitochondrion (15), cytosol
(15), dynein complex (3), microbody (4),
peroxisome (4), cell fraction (11),
secretory granule (4), organelle envelope




Intracellular transport (7), protein
localization (7), cytoskeletal
organization (5), regulation of protein
complex assembly (3), microtubule
based process (4), calmodulin binding
(4), motor activity (4), actin binding (5),
serine hydrolase activity (3),
phospholipid binding (3)
Cell motility and localization (6), cellular
iron ion hemostasis (3), cell migration
(5), cell motion (6), cell adhesion (7),
integrin-mediated signaling pathway
(3), macromolecular complex assembly
(6), response to wounding (5),
regulation of neurological system
process (3), Ca ion binding (8),
peptidase activity (5), carbohydrate
binding (4), microfilament motor
activity (2), structural molecule
activity (5)
Actin filament based process (9),
oxidation reduction (12), integrin
mediated signaling pathway (5),
cytoskeleton organization (9), proteolysis
(14), cell motion (9), defense response
(9), intracellular transport (8), cell-cell
adhesion (5), oxygen and ROS metabolic
process (3), actin binding (10), exo- or
endo-peptidase activity (6), cytoskeletal
protein binding (11), calcium ion binding
(11), cofactor binding (8), peptidase
activity (11), antioxidant activity (3)
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Glycerolipid metabolic process (6), lipid
hemostasis (4), oxidation reduction (11),
single fertilization (4), protein-lipid complex
remodeling (3), sexual reproduction (8),
protein folding (5), sterol transport (3),
response to oxidative stress (5), lipid
binding (11), carbohydrate binding (8),
glycosaminoglycan binding (5), oxidoreductase
activity (3), antioxidase activity (3)
Actin filament organization (4), protein
folding (5), negative regulation of
cellular metabolic process (5), sexual
reproduction (7), protein tetramerization
(3), oxidation reduction (8), gamete
generation (6), cell redox homeostasis
(3), protein oligomerization (4),
generation of precursor metabolites and
energy (5); motor activity (6), enzyme
inhibitor activity (6), proteasome
regulator activity 92), protein binding (7),
nucleoside binding (12), nucleotide
binding (15), protein homodimerization
activity (5)
Sexual reproduction (11), reproductive
process in a multicellular organism (10),
gamete generation (9), spermatogenesis
(8), protein folding 95), glycerophospholipid
metabolic process (4), spermatid
development/differentiation (3); purine
nucleotide binding (24), ATP binding
(18), microtubule motor activity (3),
sterol transporter activity (2), cAMP
dependent protein kinase regulator activity
(2), glutathione transferase activity (2)
Activated
pathways
Ether lipid metabolism (2), Synaptic
proteins at the synaptic junction (2);
ECM-receptor interaction (5), Integrin
cell surface interactions (4)
Leukocyte transendothelial migration
(5), focal adhesion (8), ECM-receptor
interaction (4), Adherens junction (4),
Hemostasis (7), Apoptosis (5),
Metabolism of lipids and lipoproteins
(5), metabolism of amino acids (5),
Wntsignaling (3), Integrin signaling




Gluconeogenesis (3), metabolism of
carbohydrates (4), hemostasis (5)
Fructose and mannose metabolism (3),
apoptosis (4), metabolism of amino acids
(4)
Glycolysis/gluconeogenesis (3),
adipocytokine signaling pathway (3),
PPAR signaling pathway (3), metabolism
of lipids and lipoproteins (5), Integration
of energy metabolism (5), mechanism of





Regulation of cellular protein metabolic
process (2), endocytosis (1), PTM (1)
Organelle fusion (2), protein
homodimerization activity (2),
anti-apoptosis (2), ribosomal
subunit (2), cytosol (3), membrane (4),
polymorphism (5)
Disulfide bond (7), signal peptide (6),
alternative splicing (8), metal ion binding
(7), glycoprotein (8), secreted (4),
endocytosis (2), aging (2), plasma





MAPK signaling pathway (2), Regulation of
actin cytoskeleton (2), metabolism of
vitamins and cofactors (2)
Tissue morphogenesis (3), tube
development (3), embryonic
morphogenesis (3), leucine rich repeat (3),
extracellular region (5), glycoprotein (5),
membrane (3), urogenital system
development (2)
Transmembrane (3), alternative splicing
(3), transport (4), metabolism of vitamins
and cofactors (1)
Bold text = Overexpressed proteins; regular text = Underexpressed proteins; italics text = unique processes or functions; number in parenthesis = number of proteins.
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tion and distribution, as well as processes and functions
that were either activated or suppressed in each of the
three groups are all summarized in Table 3. The number
of proteins associated with each category is shown in
parentheses. The fertile control group as well as in each
ROS group is also summarized in Table 3.
STRAP analysis of DEP in low, medium and high ROS group
STRAP analysis identified 6 DEPs (CLGN, TPP2, DNAI2,
HSPA4L, EEA1 and SERPINA5) associated with key re-
productive related functions. The differential expression
of these proteins in the three ROS groups is shown in
Table 4.
Discussion
Male infertility is a multifactorial condition emerging from
a wide variety of etiologies including gene mutations, mal-
formation of reproductive organs, infectious disease, orenvironmental exposure to toxicants [42]. In the present
study, the age of men with oxidative stress was compar-
able to that of fertile donors. The majority of the patients
(73.2%) presented with either Low ROS, Medium ROS, or
High ROS. Semen analysis was performed according to
the new WHO 2010 criteria [20]. No significant differ-
ences were observed in sperm concentration, motility or
presence of round cells between men presenting with Low
ROS, Medium ROS and High ROS. Poor sperm morph-
ology was seen in men in the high ROS group when com-
pared to Medium ROS and Low ROS group.
Some abnormal sperm morphologies are genetically-
determined while others are caused as a result of re-
peated physiological and environmental stresses. These
abnormal morphologies are reversible; however, after
repeated stress attacks, the testis may fail to fully re-
cuperate and could result in a permanent decrease in
number of sperm with normal morphology. These ab-
normalities can be explained by the effect of elevated










Possible reasons for protein
expression and relation to infertility
Reference
O14967 Calmegin CLGN Essential for formation of normal
spermatozoa. Important role in
spermatogenesis, acts as a
chaperone for a range of client
proteins that are important for sperm
adhesion onto the egg zona
pellucida and for subsequent






Its expression is triggered in case of
elevated oxidative stress. Thus, in
men with ROS generation above
physiological levels (oxidative stress),
calmegin overexpression may impair
the ability of spermatozoa to bind to
the zona pellucida. Hence, it may be a




TPPII Tripeptidyl peptidase II is a
‘multi-purpose peptidase’ with
house-keeping function in intracellular
protein degradation and plays a role
in several vital cellular processes such
as cell division, apoptosis or antigen
processing. TPPII regulates sperm
function by modifying the levels
of tyrosine phosphorylation. It is
involved in the fertilization process,






Overexpression of TPPII in men with
ROS generation above physiological
levels may modify sperm protein
tyrosine phosphorylation levels,
such that spermatozoa is unable
to undergo protein tyrosine
phosphorylation-associated processes







DNAI2 Part of the dynein complex of
respiratory cilia. DNAI2 can result in







The underexpression of DHAI2 in men
with ROS above physiological levels
may contribute to the negative effect

















Its unique expression in the 3 ROS
groups suggests that EEA1 may be
involved in the failure of acrosome









Apg-1 encodes a heat shock protein
belonging to the Hsp110 family and
is inducible by a 32 degrees C to 39
degrees C heat shock in somatic
cells. In mouse testicular germ cells
Apg-1 mRNA is constitutively
expressed
depending on the developmental
stage. It belongs to the HSP110 heat
shock gene family and is produced
ubiquitously and predominantly in
the testis. It is highly expressed in
the spermatogenic cells, from late
pachytene spermatocytes to post







The underexpression of HSPA4L in
men with ROS above physiological
levels may disrupt the normal
spermatogenesis process which may











SERPINA5 is a heparin-dependent
serine protease inhibitor that acts on
body fluids and secretions. Serine
protease with lys and arg ester bond
specificity is involved in the control
of sperm motility. SERPINA5 inhibits
the serpin acrosin and indirectly
protects the component of the male
genital tract from being degraded
by excessive released acrosin. It also
inhibits tissue-and urinary-type
plasminogen activator, prostate-specific
antigen and kallikrein activities and has







Underexpression of SERPINA5 in
men with ROS generation above
physiological levels suggests that
the reduced motility seen in these
infertile patients may be due to the
serine protease inhibiting action of
SERPINA 5.
[39-41]
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cently demonstrated the association of teratozoospermia
with increased levels of ROS [43]. Basic semen analysis is
not adequate to reflect all the parameters of semen quality
and function that are required for an optimum fertility
status especially in cases of idiopathic male factor infertil-
ity. Mature spermatozoa are particularly susceptible to
ROS damage because of the polyunsaturated nature of the
sperm plasma membrane and the absence of any tran-
scriptional activity [3,6].
ROS has been shown to be an independent marker of
oxidative stress. ROS levels can predict male factor infer-
tility (MFI) with an accuracy of ≥80% [30]. ROS-induced
oxidative stress has been shown to be a significant risk
factor associated with male factor infertility [11]. We
postulated the mechanisms for infertility among non-
leukocytospermic patients with normal semen parame-
ters and high or normal ROS levels. These were (1) dir-
ect generation of oxygen radicals by low concentrations
of leukocytes; (2) significant DNA damage in samples
containing abnormal levels of ROS-producing spermato-
zoa; (3) diminished levels of antioxidants in the seminal
plasma; or (4) the presence of immature sperm in sub-
stantial quantities in semen [3,44,45].
High ROS levels are known to significantly affect pro-
teins and lipids, induce apoptosis and cause DNA dam-
age, leading to male infertility [46]. Cells that are in a
state of oxidative stress are more likely to have altered
protein expression. Utilizing novel proteomic tools and
bioinformatics we have recently demonstrated the effect
of increased ROS levels on protein alterations seen in
the spermatozoa and seminal plasma of subjects demon-
strating high ROS levels when compared to those with
physiological levels [17,18].
The proteome provides a dynamic understanding of
post-genomic events and characterizing these events will
further our understanding of the underlying functional
changes in men diagnosed with various male-infertility-
associated etiologies [47,48]. Current literature suggests
that while causes of elevated oxidative stress levels are
multifactorial, current management of oxidative stress
is unable to accurately predict the benefit for male
infertility.
In the present study, the Reactome software showed
that DEPs in Low, Medium or High ROS group were in-
volved in the metabolism of proteins, immune system,
disease, transmembrane (TM) transport, extracellular
matrix organization, signal transduction, post-translational
modifications, and cellular response to stress. (Figures 4
and 5). DAVID analysis indicated that DEPs were involved
in the cellular functions of lipid metabolism, small mol-
ecule biochemistry, and nucleic acid metabolism (Table 3).
The overexpression of these proteins increased with in-
creasing ROS levels indicating an overactivity of proteinfunction in response to stress. In an excellent review by
Amaral et al. [19], the authors demonstrated that the
pathways involved in metabolism and energy production
have been recognized as the most significant cellular path-
way in the human spermatozoa. These authors further
showed that 26% of the proteins contributing to the reac-
tome belong to the Metabolism and energy production
group. The contribution by the metabolism and energy
groups comprised of the following: Glycolysis and gluco-
neogenesis (8%), Krebs cycle (13%), Mitochondrial electron
transport chain/oxidative phosphorylation (20%), lipid me-
tabolism (24%), amino acid metabolism (9%), nucleotide
metabolism (7%) and other carbohydrate pathways (9%).
Human sperm can utilize carbohydrate, lipid as well as
nucleotide metabolism as an energy source. An increasing
body of data suggests that mitochondrial activity is intim-
ately related to sperm function such as sperm motility and
fertilization. The sperm proteome is also enriched in
proteins related to protein metabolism which include
pathways implicated in protein translation, folding,
post-translational modifications and protein degradation.
The overexpressed proteins were seen in all ROS groups
with varying distribution of the cellular pathways as
shown by the reactome analysis.
The role of membrane trafficking is well known in
spermiogenesis. The sperm proteome is enriched in pro-
teins that mediate membrane fusion and promotes the
release of acrosomal contents. The proteins involved in
the final sperm-oocyte fusion event are also present in
the sperm proteome. Many of the overexpressed proteins
are also involved in signal transduction, extracellular
matrix organization and cellular response to stress.
Many of the DEP that were underexpressed in the 3
ROS groups were also involved in the important path-
ways such as metabolism of proteins and lipids, signal
transduction, biological oxidations, post-translational pro-
tein modifications, metabolism of proteins, transmem-
brane transport of small molecules, signal transduction,
apoptosis, and cellular response to stress.
Compared to the Low ROS group, there were proteins
that were uniquely expressed in the fertile control group.
These were involved in disease, apoptosis, biological oxi-
dation, signal transduction and immune system. In the
medium ROS group, the proteins that were uniquely
expressed in the fertile group were involved in events
such as metabolism, metabolism of lipids and lipoproteins,
signaling by Wnt and by Robo receptor, hemostasis and
signal transduction. Compared to the High ROS group,
DEP that were uniquely expressed in the fertile group
were involved in metabolism, electron transport from
NADPH to ferrodoxin, synthesis of phosphatidylinositol
phosphate (PIP) at the Golgi membrane, phospholipid
metabolism, mitochondrial iron-sulfur cluster biogen-
esis, metabolism of lipids and lipoproteins as well as
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signaling, cell signaling and membrane trafficking.
The Reactome analysis also identified proteins that
were uniquely expressed in each ROS group. Proteins
that were unique to the Low ROS group were involved
in Toll-like Receptor 9 (TLR9) cascade, toll-like receptor
cascades, and innate immune system. These receptors me-
diate response to unmethylated CpG dinucleotides in bac-
terial DNA to trigger an immune response. The presence
of these receptors may be indicative of leukocyte contam-
ination in ROS generating semen samples. Proteins that
were uniquely expressed in the Medium ROS group were
involved in disease, gene expression, metabolism of pro-
teins, toll-like receptors cascades, nuclear import of Rev
proteins and both innate and adaptive immune system. In-
nate immunity is an inherent immunity (defense) that is
already present at birth.
Similarly in the High ROS group, a significantly high
percentage of uniquely expressed proteins were involved
in metabolism, electron transport from NADPH to fer-
redoxin, and metabolism of the phospholipids, lipids,
lipoprotein synthesis of PIP at the Golgi membrane sug-
gesting that these proteins were playing a key role in opti-
mal spermatozoa function. On the other hand, in the
patients within the High ROS group, proteins were unique
and involved in cellular response to stress, signal trans-
duction, metabolism of proteins, metabolism of lipids and
lipoproteins suggesting that these proteins were operating
under high oxidative stress conditions that was affecting
the metabolic activity of the sperm and in signal transduc-
tion and response to stress.
The most significant pathways in the male gamete
are those involved in protein metabolism, membrane
trafficking, apoptosis, cell cycle, hemostasis and mei-
osis. Developmental biology and extracellular matrix
organization were also detected as putative sperm
pathways but with lower probability. Signaling trans-
duction is not a major pathway but some signaling
pathways that are seen to be active include signaling
by Wnt proteins, a family of secreted lipid-modified
signaling glycoproteins [19]. The overexpression/under
expression or the unique presence of the proteins in
the ROS groups only compared to the fertile group is
indicative of the problems in the sperm functions that
are affected or altered as a result of increased pres-
ence of ROS in these men. These alterations may be
responsible for poor fertility seen in these men com-
pared to the fertile men.
We also demonstrated that while oxidative phosphoryl-
ation is important for sperm function, the major pathway
for energy metabolism was the glycolytic pathway. Ma-
jority of the proteins were involved in cellular metabolic
and regulatory processes. We demonstrated in our earlier
work that a number of proteins that were overexpressedor underexpressed in ROS+ group were involved in cellular
processes, metabolic process, response to stress and
transport. Furthermore, a small number of proteins
were involved in post-translational processes and protein
folding [18].
DAVID software also identified a number of proteins
that were involved in key functions in the 3 ROS
groups. In the functional categories related to reproduc-
tion and/or spermatogenic events, 12 proteins were
identified in the low ROS group, 109 in the medium
ROS and 44 in the high ROS group that may be
modified and were underexpressed compared to the
fertile group. The various functional annotations are
shown in Table 3.
The majority of the overexpressed proteins were asso-
ciated with various functions such as acetylation, phos-
phoproteins, Ca2+ ion binding, oxidoreductase, defense
response, protein transport, etc. whereas other proteins
involved in signal peptide, nucleotide, binding, gamete
generation, spermatogenesis, protein folding and sperm-
atid development were underexpressed especially in the
high ROS group. This is the category with the largest
distribution of proteins that were differentially expressed
highlighting the deviation of the various functions from
the fertile group.
We further identified the DEPs in all 3 ROS groups
that are known to play a role in reproduction and
spermatogenesis that were underexpressed, over or were
uniquely expressed to each of the 3 ROS groups com-
pared to the fertile controls (Table 4). These proteins
highlight the deviation from the normal functions that are
seen in fertile men in the presence of physiological levels
of ROS. We identified 6 DEP (Calmegin, Tripeptidyl pep-
tidase II, Dynein intermediate chain 2, axonemal, Heat
shock 70 kDa protein 4L, Early endosome antigen 1, and
Plasma serine protease inhibitor) that were present in all
the 3 ROS groups with varying expression levels and
therefore may serve as potential candidates of oxidative
stress (Table 4).
In conclusion, we have for the first time demonstrated
poor sperm quality that is associated with elevated oxi-
dative stress level by categorizing the patient semen
samples into low, medium and high ROS groups. These
abnormalities can be explained by the altered expres-
sion of specifically DEPs Calmegin, tripeptidyl synthe-
sase, dynein intermediate chain 2, heat shock 70 kDa
protein 4L, early endosome antigen 1, plasma serine
protease inhibitor in patient groups. These DEPs may
serve as potential biomarkers in the identification of
the effect of increasing ROS level on protein profile
of spermatozoa in infertile men. Further validation of
DEPs is necessary to establish the role of these pro-
teins as biomarkers of oxidative stress induced male
factor infertility.
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